TNF-α and NF-κB signaling play a critical role in cigarette smoke-induced epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 30 07 2021
accepted: 11 07 2022
entrez: 1 9 2022
pubmed: 2 9 2022
medline: 9 9 2022
Statut: epublish

Résumé

Proliferative vitreoretinopathy (PVR) is characterized by the growth and contraction of cellular membranes within the vitreous cavity and on both surfaces of the retina, resulting in recurrent retinal detachments and poor visual outcomes. Proinflammatory cytokines like tumor necrosis factor alpha (TNFα) have been associated with PVR and the epithelial-mesenchymal transition (EMT) of retinal pigment epithelial (RPE) cells. Cigarette smoke is the only known modifiable risk factor for PVR, but the mechanisms are unclear. The purpose of this study was to examine the impact of cigarette smoke on the proinflammatory TNFα/NF-κB/Snail pathway in RPE cells to better understand the mechanisms through which cigarette smoke increases the risk of PVR. Human ARPE-19 cells were exposed to cigarette smoke extract (CSE), for 4 to 24-hours and TNFα, Snail, IL-6, IL-8, and α-SMA levels were analyzed by qPCR and/or Western blot. The severity of PVR formation was assessed in a murine model of PVR after intravitreal injection of ARPE-19 cells pre-treated with CSE or not. Fundus imaging, OCT imaging, and histologic analysis 4 weeks after injection were used to examine PVR severity. ARPE-19 cells exposed to CSE expressed higher levels of TNFα, SNAIL, IL6 and IL8 mRNA as well as SNAIL, Vimentin and α-SMA protein. Inhibition of TNFα and NF-κB pathways blocked the effect of CSE. In vivo, intravitreal injection of ARPE-19 cells treated with CSE resulted in more severe PVR compared to mice injected with untreated RPE cells. These studies suggest that the TNFα pathway is involved in the mechanism whereby cigarette smoke increases PVR. Further investigation into the role of TNFα/NF-κB/Snail in driving PVR and pharmacological targeting of these pathways in disease are warranted.

Identifiants

pubmed: 36048826
doi: 10.1371/journal.pone.0271950
pii: PONE-D-21-24769
pmc: PMC9436090
doi:

Substances chimiques

NF-kappa B 0
Tumor Necrosis Factor-alpha 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0271950

Subventions

Organisme : NEI NIH HHS
ID : P30 EY001319
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY031398
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR002000
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Clin Med. 2016 Apr 11;5(4):
pubmed: 27077888
Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2721-35
pubmed: 18424637
Stem Cell Reports. 2020 Apr 14;14(4):631-647
pubmed: 32243845
Toxicology. 2019 Jun 15;422:84-94
pubmed: 31128153
Graefes Arch Clin Exp Ophthalmol. 2007 May;245(5):641-9
pubmed: 17119994
Biomed Res Int. 2019 Jun 24;2019:2025636
pubmed: 31341890
Invest Ophthalmol Vis Sci. 2001 Jun;42(7):1586-91
pubmed: 11381065
Cardiovasc Res. 2010 May 1;86(2):211-8
pubmed: 20202975
Curr Eye Res. 1994 Nov;13(11):791-8
pubmed: 7851114
Exp Eye Res. 2016 Jan;142:26-31
pubmed: 26675400
Dis Mon. 2018 Feb;64(2):20-57
pubmed: 28826742
Invest Ophthalmol Vis Sci. 2000 Dec;41(13):4324-32
pubmed: 11095634
Am J Physiol Cell Physiol. 2009 Nov;297(5):C1200-10
pubmed: 19759330
J Immunol. 2011 Mar 1;186(5):3206-14
pubmed: 21278339
Nat Commun. 2017 Oct 11;8(1):851
pubmed: 29021573
Science. 2005 Nov 11;310(5750):1022-5
pubmed: 16284179
Int Ophthalmol. 2020 Jun;40(6):1587-1601
pubmed: 32103371
Am J Respir Cell Mol Biol. 2004 Nov;31(5):481-2
pubmed: 15494469
Transl Vis Sci Technol. 2020 Jun 05;9(7):9
pubmed: 32832216
Front Pharmacol. 2017 Jul 12;8:460
pubmed: 28785220
Retina. 2019 Aug;39(8):1488-1495
pubmed: 29787465
Mol Vis. 2017 Dec 13;23:933-943
pubmed: 29296073
Prog Retin Eye Res. 2002 Jan;21(1):127-44
pubmed: 11906814
Int J Ophthalmol. 2016 Oct 18;9(10):1480-1486
pubmed: 27803868
Prog Retin Eye Res. 2016 Mar;51:125-55
pubmed: 26209346
Nat Protoc. 2008;3(6):1101-8
pubmed: 18546601
Front Immunol. 2018 Aug 09;9:1849
pubmed: 30140268
Respir Res. 2012 Nov 17;13:104
pubmed: 23157169
J Biol Chem. 2008 Oct 24;283(43):28944-57
pubmed: 18697742
Br J Cancer. 2010 Feb 16;102(4):639-44
pubmed: 20087353
BMJ. 2017 Jun 19;357:j2505
pubmed: 28630047
N Engl J Med. 2006 Aug 17;355(7):704-12
pubmed: 16914706
Surv Ophthalmol. 2013 Jul-Aug;58(4):321-9
pubmed: 23642514
Future Oncol. 2012 Jun;8(6):713-22
pubmed: 22764769
Curr Pharm Des. 2017;23(4):639-654
pubmed: 28078992
Dev Ophthalmol. 2016;55:154-62
pubmed: 26501375
Environ Res. 2017 Oct;158:480-489
pubmed: 28704792
Dev Ophthalmol. 1989;16:1-53
pubmed: 2676632
Clin Ophthalmol. 2012;6:1325-33
pubmed: 22942638
Br J Ophthalmol. 2009 Apr;93(4):559-60
pubmed: 19321487
Zhonghua Yan Ke Za Zhi. 1999 Mar;35(2):140-3
pubmed: 11835796
Invest Ophthalmol Vis Sci. 2013 Mar 05;54(3):1665-78
pubmed: 23258148
Int Ophthalmol Clin. 2019 Winter;59(1):221-240
pubmed: 30585928
Commun Biol. 2019 May 3;2:162
pubmed: 31069271
Blood. 2002 Sep 1;100(5):1828-34
pubmed: 12176906
BMC Cancer. 2020 Sep 22;20(1):905
pubmed: 32962699
Trends Mol Med. 2015 Jun;21(6):385-93
pubmed: 25979753
BMC Complement Altern Med. 2018 Aug 9;18(1):235
pubmed: 30092797
J Anal Toxicol. 2008 Apr;32(3):201-7
pubmed: 18397571
Crit Rev Eukaryot Gene Expr. 2010;20(2):87-103
pubmed: 21133840
Adv Exp Med Biol. 2015;887:157-70
pubmed: 26662991
Clin Exp Immunol. 2014 Jun;176(3):461-72
pubmed: 24528166
Arch Ophthalmol. 1997 Feb;115(2):237-41
pubmed: 9046259
Retina. 2017 Jul;37(7):1229-1235
pubmed: 27787448
Ophthalmology. 2006 Nov;113(11):2041-7
pubmed: 16952397
Br J Ophthalmol. 1999 Nov;83(11):1296-9
pubmed: 10535861
Mol Med Rep. 2018 Mar;17(3):3563-3574
pubmed: 29286114
PLoS One. 2020 Dec 21;15(12):e0243626
pubmed: 33347461
Prog Retin Eye Res. 2014 May;40:16-34
pubmed: 24412519
Prog Retin Eye Res. 1998 Jan;17(1):77-98
pubmed: 9537796

Auteurs

Victor Wang (V)

Flaum Eye Institute, University of Rochester Medical Center, Rochester, NY, United States of America.

Alison Heffer (A)

Flaum Eye Institute, University of Rochester Medical Center, Rochester, NY, United States of America.

Elisa Roztocil (E)

Flaum Eye Institute, University of Rochester Medical Center, Rochester, NY, United States of America.

Steven E Feldon (SE)

Flaum Eye Institute, University of Rochester Medical Center, Rochester, NY, United States of America.
Center for Visual Sciences, University of Rochester, Rochester, NY, United States of America.

Richard T Libby (RT)

Flaum Eye Institute, University of Rochester Medical Center, Rochester, NY, United States of America.

Collynn F Woeller (CF)

Flaum Eye Institute, University of Rochester Medical Center, Rochester, NY, United States of America.
Department of Environmental Medicine, School of Medicine and Dentistry, University of Rochester, Rochester, New York, United States of America.

Ajay E Kuriyan (AE)

Flaum Eye Institute, University of Rochester Medical Center, Rochester, NY, United States of America.
Center for Visual Sciences, University of Rochester, Rochester, NY, United States of America.
Retina Service/Mid Atlantic Retina, Wills Eye Hospital, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH